CD276 and neoplasm: In mouse and human solid tumor models, these synNotch CAR-T cells selectively killed EpCAM+ ROR1+ or B7-H3+ ROR1+  tumors cells  but not killed EpCAM−ROR1+ cells or B7-H3−ROR1+ cells in normal tissues, resulting in tumor regression without toxicity [125].